Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to accurately determine, using an implantable rhythm monitor,
the long-term incidence of new atrial fibrillation after ablation of atrial flutter in those
treated with spironolactone compared with standard medical therapy.